• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃肠胰神经内分泌肿瘤¹¹¹铟-奥曲肽单光子发射计算机断层显像校正方法的评估

Evaluation of a Correction Method for In-Pentetreotide SPECT Imaging of Gastroenteropancreatic Neuroendocrine Tumors.

作者信息

Kanzaki Takao, Takahashi Yasuyuki, Higuchi Tetsuya, Zhang Xieyi, Mogi Nao, Suto Takayuki, Tsushima Yoshito

机构信息

Department of Radiology, Gunma University Hospital, Gunma, Japan

Department of Nuclear Medicine Technology, Hirosaki University Graduate School of Health Sciences, Aomori, Japan.

出版信息

J Nucl Med Technol. 2020 Dec;48(4):326-330. doi: 10.2967/jnmt.120.249680. Epub 2020 Sep 4.

DOI:10.2967/jnmt.120.249680
PMID:32887762
Abstract

The number of patients with the extremely rare disease gastroenteropancreatic (GEP) neuroendocrine tumor (NET) has increased rapidly in recent years. In-pentetreotide SPECT in somatostatin receptor scintigraphy has been used for the assessment of GEP NET patients. To diagnose GEP NET, appropriate selection of image correction parameters is critical. Correction methods may improve the In-pentetreotide SPECT image quality, but there is currently no standard technique. The purpose of this study was to determine the optimal correction parameter settings for In-pentetreotide SPECT. A phantom study produced images with a tumor-to-background ratio of as high as 16:1. A triple energy window was used for scatter correction (SC), and attenuation correction (AC) was CT-based. Correlation analysis was performed in 4 groups: no correction (NC), SC, AC, and combined SC with AC (CC). The In-pentetreotide SPECT results for 20 randomly selected patients (13 men and 7 women; age range, 37-81 y) with confirmed GEP NET were analyzed using data collected 4 h after injection of 111 MBq of In-pentetreotide. Emission data were reconstructed using ordered-subset expectation maximization (OSEM) with different settings. Different combinations of the correction parameters were used to analyze the contrast-to-noise ratios (CNRs) obtained with the phantom. In the clinical study, 20 GEP NET patients were used to evaluate the GEP NET lesion CNR by 4 different image correction methods obtained from In-pentetreotide SPECT images: NC, SC, AC, and CC. NC was used as a reference method. The phantom study revealed that the optimal energy window in the photopeak for somatostatin receptor scintigraphy was 171 keV ± 10% and 245 keV ± 7.5%, and the optimal OSEM reconstruction conditions were 8 subsets and 6 iterations. Among the OSEM collection conditions, CC produced a significantly higher CNR than NC or SC ( < 0.05). In the clinical study, CC was found to increase the CNR ( < 0.05). CC improves the correction in In-pentetreotide SPECT studies, compared with NC, providing better contrast and sharper outlines of lesions and organs.

摘要

近年来,极罕见的胃肠胰(GEP)神经内分泌肿瘤(NET)患者数量迅速增加。生长抑素受体闪烁显像中的铟-喷曲肽单光子发射计算机断层扫描(SPECT)已用于评估GEP NET患者。为诊断GEP NET,正确选择图像校正参数至关重要。校正方法可能会改善铟-喷曲肽SPECT图像质量,但目前尚无标准技术。本研究的目的是确定铟-喷曲肽SPECT的最佳校正参数设置。一项体模研究生成了肿瘤与背景比值高达16:1的图像。采用三能量窗进行散射校正(SC),衰减校正(AC)基于CT。在四组中进行相关性分析:无校正(NC)、SC、AC以及SC与AC联合(CC)。对20例经确诊的GEP NET患者(13例男性和7例女性;年龄范围37 - 81岁)进行铟-喷曲肽SPECT检查,在注射111 MBq铟-喷曲肽4小时后收集数据并进行分析。发射数据使用不同设置的有序子集期望最大化(OSEM)进行重建。使用校正参数的不同组合分析体模获得的对比噪声比(CNR)。在临床研究中,20例GEP NET患者用于通过从铟-喷曲肽SPECT图像获得的4种不同图像校正方法评估GEP NET病变的CNR:NC、SC、AC和CC。NC用作参考方法。体模研究表明,生长抑素受体闪烁显像光电峰的最佳能量窗为171 keV±10%和245 keV±7.5%,最佳OSEM重建条件为8个子集和6次迭代。在OSEM采集条件中,CC产生的CNR显著高于NC或SC(<0.05)。在临床研究中,发现CC可提高CNR(<0.05)。与NC相比,CC改善了铟-喷曲肽SPECT研究中的校正,提供了更好的病变和器官对比度以及更清晰的轮廓。

相似文献

1
Evaluation of a Correction Method for In-Pentetreotide SPECT Imaging of Gastroenteropancreatic Neuroendocrine Tumors.胃肠胰神经内分泌肿瘤¹¹¹铟-奥曲肽单光子发射计算机断层显像校正方法的评估
J Nucl Med Technol. 2020 Dec;48(4):326-330. doi: 10.2967/jnmt.120.249680. Epub 2020 Sep 4.
2
Optimization of image reconstruction method for SPECT studies performed using [⁹⁹mTc-EDDA/HYNIC] octreotate in patients with neuroendocrine tumors.使用[⁹⁹mTc-乙二胺二乙酸/羟基乙腈]奥曲肽对神经内分泌肿瘤患者进行单光子发射计算机断层显像(SPECT)研究时图像重建方法的优化
Nucl Med Rev Cent East Eur. 2013;16(1):9-16. doi: 10.5603/NMR.2013.0003.
3
Clinical Usefulness of Somatostatin Receptor Scintigraphy in Japanese Patients with Gastroenteropancreatic Neuroendocrine Tumors.生长抑素受体闪烁扫描术在日本胃肠胰神经内分泌肿瘤患者中的临床应用价值
Digestion. 2017;96(1):13-20. doi: 10.1159/000470838. Epub 2017 Jun 14.
4
Incremental diagnostic value and impact on patient management of somatostatin receptor scintigraphy with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors.胃-肠-胰神经内分泌肿瘤中应用铟-111 标记喷替酸五肽进行生长抑素受体闪烁扫描的诊断增值作用及其对患者处理的影响。
Med Princ Pract. 2011;20(4):356-61. doi: 10.1159/000323762. Epub 2011 May 11.
5
Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.生长抑素受体闪烁扫描术在胃肠胰神经内分泌肿瘤肝转移检测中的应用
J Nucl Med. 2003 Mar;44(3):359-68.
6
Somatostatin receptor scintigraphy with 111In-pentetreotide in non-functioning gastroenteropancreatic neuroendocrine tumors.使用111铟-奥曲肽进行生长抑素受体闪烁扫描在无功能性胃肠胰神经内分泌肿瘤中的应用
Int J Oncol. 2003 Dec;23(6):1687-95.
7
Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors.68Ga-DOTATATE PET/CT在神经内分泌肿瘤诊断、分期及治疗管理中的安全性与有效性
J Nucl Med. 2016 May;57(5):708-14. doi: 10.2967/jnumed.115.163865. Epub 2016 Jan 14.
8
Reconstruction parameters for 111In-pentetreotide SPECT: variability with respect to body weight and body region.111铟-喷替膦酸单光子发射计算机断层扫描的重建参数:与体重和身体部位相关的变异性
J Nucl Med Technol. 2007 Dec;35(4):237-41. doi: 10.2967/jnmt.107.040402. Epub 2007 Nov 15.
9
Contribution of ¹¹¹In-pentetreotide SPECT/CT imaging to conventional somatostatin receptor scintigraphy in the detection of neuroendocrine tumours.¹¹¹铟-喷曲肽单光子发射计算机断层显像/计算机断层扫描成像在神经内分泌肿瘤检测中对传统生长抑素受体闪烁显像的贡献
Nucl Med Commun. 2015 Mar;36(3):251-9. doi: 10.1097/MNM.0000000000000239.
10
Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management.用铟-111-喷曲肽进行生长抑素受体显像在胃肠胰神经内分泌肿瘤中的应用:安全性、有效性及对患者管理的影响
J Nucl Med. 1995 Apr;36(4):542-9.

引用本文的文献

1
Direct attenuation correction for Tc-3PRGD chest SPECT lung cancer images using deep learning.利用深度学习对Tc-3PRGD胸部SPECT肺癌图像进行直接衰减校正。
Front Oncol. 2023 May 12;13:1165664. doi: 10.3389/fonc.2023.1165664. eCollection 2023.
2
Advances in the Diagnosis and Therapeutic Management of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs).胃肠胰神经内分泌肿瘤(GEP-NENs)的诊断与治疗进展
Cancers (Basel). 2022 Apr 17;14(8):2028. doi: 10.3390/cancers14082028.
3
Role of Combined Ga DOTA-Peptides and F FDG PET/CT in the Evaluation of Gastroenteropancreatic Neuroendocrine Neoplasms.
镓标记的DOTA肽与氟代脱氧葡萄糖PET/CT联合应用在胃肠胰神经内分泌肿瘤评估中的作用
Diagnostics (Basel). 2022 Jan 22;12(2):280. doi: 10.3390/diagnostics12020280.